Condition
Lymphatic Disorders
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting1
Unknown1
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT00833599Enrolling By Invitation
Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
NCT07131293RecruitingPrimary
European Registry Study on Lymphatic Interventions
NCT04273334Phase 1UnknownPrimary
Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders
Showing all 3 trials